These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
336 related items for PubMed ID: 3280741
21. A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patients. Zori Comba A, Blajman C, Richardet E, Bella S, Vilanova M, Cóppola F, Van Kooten M, Rodger J, Giglio R, Balbiani L, Perazzo F, Montiel M, Chacón M, Pujol F, Mickiewicz E, Cazap E, Recondo G, Lastiri F, Simon J, Wasserman E, Schmilovich A. Eur J Cancer; 2001 May; 37(8):1006-13. PubMed ID: 11334726 [Abstract] [Full Text] [Related]
22. Toxicity analysis of the 5-day bolus 5-fluorouracil/folinic acid regimen for the treatment of colorectal carcinoma from 2 randomized controlled trials: a concern about dose. Vincent M, Ho C, Tomiak A, Winquist E, Whiston F, Stitt L. Clin Colorectal Cancer; 2002 Aug; 2(2):111-8. PubMed ID: 12453326 [Abstract] [Full Text] [Related]
28. Weekly 24-h infusion of high-dose 5-fluorouracil (5-FU) with folinic acid (FA) in adjuvant therapy of colon cancer. Wein A, Riedel C, Brückl W, Kastl S, Reingruber B, Hohenberger W, Hahn EG. Z Gastroenterol; 2001 Feb; 39(2):153-6. PubMed ID: 11253506 [Abstract] [Full Text] [Related]
29. A phase II study of continuous infusion 5-fluorouracil and leucovorin with weekly cisplatin in metastatic colorectal carcinoma. Grem JL, McAtee N, Balis F, Murphy R, Venzon D, Kramer B, Goldspiel B, Begley M, Allegra CJ. Cancer; 1993 Aug 01; 72(3):663-8. PubMed ID: 8334622 [Abstract] [Full Text] [Related]
30. Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysis. Klaassen U, Wilke H, Pari CP, Strumberg D, Harstrick A, Eberhardt W, Becher R, Diergarten K, Seeber S. Semin Oncol; 1995 Dec 01; 22(6 Suppl 14):7-11. PubMed ID: 8553083 [Abstract] [Full Text] [Related]
31. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer. Yamada Y, Ohtsu A, Boku N, Miyata Y, Shimada Y, Doi T, Muro K, Muto M, Hamaguchi T, Mera K, Yano T, Tanigawara Y, Shirao K. Jpn J Clin Oncol; 2006 Apr 01; 36(4):218-23. PubMed ID: 16684860 [Abstract] [Full Text] [Related]
32. A prospective randomized trial of fluorouracil versus fluorouracil plus cisplatin in the treatment of metastatic colorectal cancer: a Hoosier Oncology Group trial. Loehrer PJ, Turner S, Kubilis P, Hui S, Correa J, Ansari R, Stephens D, Woodburn R, Meyer S. J Clin Oncol; 1988 Apr 01; 6(4):642-8. PubMed ID: 3282033 [Abstract] [Full Text] [Related]
37. Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin: results of a multicentric prospective trial of fluorouracil dosage optimization by pharmacokinetic monitoring in 152 patients. Gamelin E, Boisdron-Celle M, Delva R, Regimbeau C, Cailleux PE, Alleaume C, Maillet ML, Goudier MJ, Sire M, Person-Joly MC, Maigre M, Maillart P, Fety R, Burtin P, Lortholary A, Dumesnil Y, Picon L, Geslin J, Gesta P, Danquechin-Dorval E, Larra F, Robert J. J Clin Oncol; 1998 Apr 01; 16(4):1470-8. PubMed ID: 9552054 [Abstract] [Full Text] [Related]
38. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma]. Popov I, Jelić S, Radosavljević D, Nikolić-Tomasević A. Srp Arh Celok Lek; 1998 Apr 01; 126(9-10):355-61. PubMed ID: 9863407 [Abstract] [Full Text] [Related]
40. A randomised phase III intergroup trial comparing high-dose infusional 5-fluorouracil with or without folinic acid with standard bolus 5-fluorouracil/folinic acid in the adjuvant treatment of stage III colon cancer: the Pan-European Trial in Adjuvant Colon Cancer 2 study. Köhne CH, Bedenne L, Carrato A, Bouché O, Popov I, Gaspà L, Valladares M, Rougier P, Gog C, Reichardt P, Wils J, Pignatti F, Biertz F. Eur J Cancer; 2013 May 01; 49(8):1868-75. PubMed ID: 23571150 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]